|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
6.220 -0.300 (-4.601%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 2,170,339 | 1.467% | 2,138,952 | 1,931,212 | 2,127,879 | 1,869,740 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 858,260 | 55.289% | 552,684 | 232,479 | 249,896 | 176,242 |
| Interests in Asso. & JCEs | 150,571 | 1492.501% | 9,455 | 9,265 | 215,820 | 164,429 |
| Other Non-current Assets | 2,035,553 | -22.585% | 2,629,409 | 3,008,638 | 1,882,983 | 1,658,818 |
| 5,214,723 | -2.172% | 5,330,500 | 5,181,594 | 4,476,578 | 3,869,229 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 614,562 | 101.641% | 304,780 | 235,157 | 262,673 | 248,174 | |
| Trade Receivables | 2,631,645 | 12.520% | 2,338,830 | 2,398,767 | 1,871,012 | 1,336,916 | |
| Cash & Bank Balances | 2,007,162 | 21.036% | 1,658,312 | 973,139 | 3,270,241 | 354,804 | |
| Other Current Assets | 385,575 | -66.661% | 1,156,530 | 1,372,486 | 1,062,906 | 957,747 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 5,638,944 | 3.307% | 5,458,452 | 4,979,549 | 6,466,832 | 2,897,641 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 317,218 | -5.430% | 335,433 | 323,951 | 242,077 | 254,851 | ||
| S-T Debt & Leases | 1,094,981 | -18.940% | 1,350,823 | 1,561,643 | 1,831,038 | 1,670,184 | ||
| Other Current Liabilities | 1,273,701 | -0.520% | 1,280,362 | 1,178,169 | 1,424,043 | 1,503,470 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 2,685,900 | -9.463% | 2,966,618 | 3,063,763 | 3,497,158 | 3,428,505 | |||
| Net Current Assets | 2,953,044 | 18.509% | 2,491,834 | 1,915,786 | 2,969,674 | (530,864) | ||
| Total Assets Less Current Liabilities | 8,167,767 | 4.416% | 7,822,334 | 7,097,380 | 7,446,252 | 3,338,365 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 334,243 | 114.367% | 155,921 | 74,239 | 1,468,980 | 1,270,772 | |||
| Other Non-current Liabilities | 610,788 | 17.767% | 518,641 | 560,384 | 641,548 | 587,129 | |||
| 945,031 | 40.095% | 674,562 | 634,623 | 2,110,528 | 1,857,901 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 3,173,805 | 3.008% | 3,081,131 | 3,002,871 | 3,002,871 | 210 | ||||
| Reserves | 4,048,931 | -0.041% | 4,050,579 | 3,434,126 | 2,298,918 | 1,480,254 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 7,222,736 | 1.276% | 7,131,710 | 6,436,997 | 5,301,789 | 1,480,464 | ||||
| Non-controlling Interests | 0 | -- | 16,062 | 25,760 | 33,935 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 7,222,736 | 1.049% | 7,147,772 | 6,462,757 | 5,335,724 | 1,480,464 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 586,333 | 108.105% | 281,749 | 112,677 | 127,910 | 285,066 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 13/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 456,600 |
| %Change | -79.918% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.716 |